Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 467 followers
Latest posts
Last updated 1 day ago
Statement: Zantac (ranitidine) litigation – Russell and Hughes cases
1 day ago
GSK confirmed it has reached two confidential settlements in cases filed in...
Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple myeloma accepted for regulatory review in Japan
2 days ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials.
Blenrep (belantamab mafodotin) in combination receives Breakthrough Therapy Designation in China for treatment of relapsed/refractory multiple myeloma
6 days ago
Granted based on results from phase III head-to-head DREAMM-7 trial.
GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme
7 days ago
Data support progression to phase III clinical trials.
Statement: Zantac (ranitidine) litigation – Dixon case
8 days ago
GSK confirmed it has reached a settlement with Mr. Isaac Dixon, resolving...
GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trial
8 days ago
Results show that GSK3943104 did not meet the study’s primary efficacy objective.
Depemokimab late-breaking data presented at ERS show a 54% reduction in severe asthma exacerbations
10 days ago
SWIFT-1 and SWIFT-2 phase III data show depemokimab delivered statistically significant and...
GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD
13 days ago
GSK announces positive headline results of MATINEE, the phase III clinical trial...
GSK aims to redefine the future of respiratory medicine at the European Respiratory Society International Congress
16 days ago
Presenting 56 abstracts to advance scientific understanding and support ambition to improve...
European Commission approves expanded age indication for GSK’s Arexvy, the first respiratory syncytial virus (RSV) vaccine for adults aged 50-59 at increased risk
21 days ago
Authorisation helps protect this population for the first time ahead of this...
Bepirovirsen granted SENKU designation in Japan for chronic hepatitis B
22 days ago
Designation expedites review of bepirovirsen as a potential treatment for people living...
GSK’s Nucala (mepolizumab) approved in Japan for treatment of adults with chronic rhinosinusitis with nasal polyps
22 days ago
Nucala is the first and only biologic in Japan with a four-weekly...